Project Grant CLSS00000066524

The U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $75,500,157 Project Grant under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) to the Government of the District of Columbia. The grant, titled "DCOR 4 - The District of Columbia's Opioid Response 4 (DCOR 4) Initiative", will focus on addressing the opioid overdose crisis by increasing access to medication for opioid use disorder (MOUD),...

This $598,312 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate and assess the practicality of a closed-loop medication management system for opioid pain management in emergency department patients with extremity fractures. The key product being developed and evaluated is the ADDINEX system, which packages opioid medications in mechanical dispensers that restrict access to individual...

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

The National Institute on Drug Abuse (NIDA) awarded a $267,000 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to develop depot formulations for on-demand, tamper- and diversion-proof delivery of opioids. The project aims to create injectable, polymer-based depot formulations that covalently bond opioids using photolabile linkers. This approach would prevent tampering and diversion, while...

The National Institute on Drug Abuse (NIDA) awarded a $193,336 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Trustees of Dartmouth College to evaluate a pharmacist-integrated model of opioid use disorder (OUD) treatment in primary care settings. The goal is to investigate if this model can increase the co-prescribing of naloxone, the opioid overdose antidote, to patients receiving medication treatment for OUD. The research project aims to: 1) describe federal,...

The National Institute on Drug Abuse (NIDA) awarded a $220,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Amalgent Therapeutics, Inc. in Greenville, NC. This grant supports the development of a novel opioid adjuvant technology that aims to enhance the pain-relieving efficacy of opioid medications while mitigating risks such as abuse potential, tolerance, and neuropathic pain. The project has two key objectives: 1) investigating the mechanism by which the...

The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance awarded a $1,600,000 Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) Project Grant to the Southern Nevada Health District (SNHD) and sub-recipients Las Vegas Metropolitan Police Department (LVMPD) and University of Nevada, Las Vegas (UNLV). The grant will fund a collaborative initiative to address the opioid crisis in Clark County, Nevada through a public health-focused overdose...

This federal Project Grant award for $1,499,606 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to characterize health outcomes and disparities in children born to individuals with opioid use disorder (OUD). The key products and services to be delivered through this 5-year grant include: Examining variation in the diagnosis of neonatal opioid withdrawal syndrome (NOWS) across 150 hospitals and identifying...

This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,398,820 to support research on developing safer opioid analgesics and antagonists that can help address the opioid epidemic. The principal investigators at The Washington University, in collaboration with researchers at Stanford University and the University of Florida, will use structure-based design and screening approaches to...

The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,000,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Village of Alakanuk in Alaska. This 5-year grant will fund the Alakanuk Tribal Opioid Response Program, which aims to implement culturally informed and responsive community and school-based prevention education activities to raise awareness about the dangers of...